Updates

WHAT THEY ARE SAYING: BIOGEN’S “SIMPLY UNACCEPTABLE” ADUCANUMAB PRICING HIGHLIGHTS URGENCY FOR RX SOLUTIONS

Jun 14, 2021

Broad-based Opposition to Egregious Launch Price on Drug With Unproven Read More

CSRXP: FDA APPROVAL AND SUBSEQUENT BIOGEN PRICING OF ADUCANUMAB DEMAND RETROSPECTION, REFORM

Jun 11, 2021

Troubling for Public Health Institution to Depart from Established Norms to Read More

ICYMI: BIG PHARMA’S FASTER-THAN-INFLATION PRICE HIKES COSTING MEDICARE BILLIONS OF DOLLARS

Jun 7, 2021

AARP Study Finds Brand Name Drug Companies Increased Prices Above Rate of Read More

SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC

Jun 7, 2021

For far too long Big Pharma has used the excuse that research and development Read More

CSRXP AD BLITZ: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE NOW

Jun 1, 2021

Campaign Calls for Promises Made to the American People to Lower Prescription Read More

CSRXP COMMENDS PRESIDENT BIDEN FOR RENEWING COMMITMENT TO LOWERING PRESCRIPTION DRUG PRICES IN BUDGET

May 28, 2021

Time for the Administration and Congress to Convert Promises Made Into Read More

DOSE OF REALITY: HUMIRA: A CASE STUDY IN BIG PHARMA GREED

May 17, 2021

AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive Read More

THEY SAID IT! LAWMAKERS CALL FOR BIPARTISAN ACTION TO LOWER RX PRICES IN PAIR OF HOUSE HEARINGS

May 5, 2021

Members of Congress in Both Parties Recognize Urgency for Solutions to Deliver Read More

BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE & ASTRAZENECA

May 5, 2021

Drug Companies Top Wall Street Expectations; Pfizer Raises Guidance Based On Read More

BIG PHARMA EARNINGS WATCH: SANOFI, MERCK, BRISTOL-MYERS SQUIBB, AMGEN & GLAXOSMITHKLINE

May 4, 2021

Brand Name Drug Makers Boosting Profits, Sales After Engaging In Pandemic Read More

BIG PHARMA WATCH: GAO REPORT FINDS U.S. CONSUMERS PAY DOUBLE TO QUADRUPLE FOR RX DRUGS

Apr 29, 2021

Study Finds Americans Face Much Higher Drug Prices Than Patients In Other Read More